Astromech raises $20 million to build evolution early-warning ai
Astromech, co-founded by Ben Lamm and Harvard geneticist George Church, announced $20 million in new funding at a $3.8 billion valuation and plans to use genomic data from Colossal Biosciences to train AI models that predict biological change. The company says its datasets span 3.8 billion years of biological history and aims to build an early-warning system for disease, drug resistance and threats to the food chain, beginning with aging research using long-lived species like Bowhead whales and cancer-resistant Asian elephants. The firm is in research and development and must demonstrate that predictions translate into real-world results.
Astromech raised $20 million at a $3.8 billion valuation.
Context
Colossal Biosciences has built large genomic datasets and pursued de-extinction work. Astromech will use those datasets in R&D and will test models first on aging studies.
The full analysis
19 dimensions on this story — world impact, market read, and what happens next.
- Full ContextLocked
- Affected SectorsLocked
- Stock ImpactLocked
- Economic IndicatorLocked
- Investor RelevanceLocked
- Professional RelevanceLocked
- Watch PointsLocked
- Probability of ChangeLocked
- Debate PointsLocked
- Prerequisite KnowledgeLocked
- Follow-up QuestionsLocked
- Pros & ConsLocked